SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038092
Filing Date
2024-03-28
Accepted
2024-03-28 16:30:53
Documents
82
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K isco-20231231.htm   iXBRL 10-K 2012973
2 EX-23.1 isco-ex23_1.htm EX-23.1 2562
3 EX-31.1 isco-ex31_1.htm EX-31.1 11917
4 EX-31.2 isco-ex31_2.htm EX-31.2 11819
5 EX-32.1 isco-ex32_1.htm EX-32.1 6776
6 EX-32.2 isco-ex32_2.htm EX-32.2 6928
7 EX-97.1 isco-ex97_1.htm EX-97.1 30102
  Complete submission text file 0000950170-24-038092.txt   9647018

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT isco-20231231.xsd EX-101.SCH 1412318
86 EXTRACTED XBRL INSTANCE DOCUMENT isco-20231231_htm.xml XML 1840266
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51891 | Film No.: 24799596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)